User profiles for David Setyo Budi

David Setyo Budi

Faculty of Medicine, Universitas Airlangga
Verified email at fk.unair.ac.id
Cited by 155

mRNA Covid-19 vaccines in pregnancy: A systematic review

NR Pratama, IA Wafa, DS Budi, M Putra… - PLoS …, 2022 - journals.plos.org
Objective Pregnancy is a known risk factor for severe Coronavirus disease 2019. It is
important to develop safe vaccines that elicit strong maternal and fetal antibody responses. …

[PDF][PDF] Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19

DS Budi, NR Pratama, IA Wafa, M Putra, MP Wardhana… - Heliyon, 2022 - cell.com
Objective The use of remdesivir for pregnant patients with coronavirus disease 2019 (COVID-19)
showed conflicting results in prior studies. We aimed to systematically review its …

Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variant (B. 1.1. 529): a systematic review with meta-analysis and meta-regression

NR Pratama, IA Wafa, DS Budi, H Sutanto… - Vaccines, 2022 - mdpi.com
Vaccine effectiveness (VE) and the urgency of booster vaccination against SARS-CoV-2
Omicron variant need evaluation. A systematic search was conducted from 1–6 April, 2022. VE …

Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis

DS Budi, IF Rofananda, NR Pratama, H Sutanto… - International …, 2022 - Elsevier
Objective Ozone adjuvant in COVID-19 management showed conflicting results in prior
studies. Here, we aimed to comprehensively evaluate benefits and side effects of ozone as …

Automated glycemic control with a bionic pancreas for type 1 diabetes mellitus: A systematic review and meta-analysis

P Oktavian, DS Budi, IN Wibowo, RCR Rusuldi… - Diabetes & Metabolic …, 2023 - Elsevier
Background and aims The use of a bionic pancreas with automated insulin delivery systems
to prevent complications of diabetes mellitus shows conflicting results. We aimed to …

Covid-19 vaccination in pregnancy: a systematic review

NR Pratama, IA Wafa, DS Budi, M Putra, MP Wardhana… - Medrxiv, 2021 - medrxiv.org
Objective Pregnancy is a risk factor for severe Covid-19. Looking for safe vaccines that evoke
protective maternal and fetal antibody response is important. Methods We searched from …

[HTML][HTML] Clinical outcomes of opioid administration in acute and chronic heart failure: A meta-analysis

…, ES Anastasia, NP Wardhani, DS Budi… - Diabetes & Metabolic …, 2022 - Elsevier
Background and aims Opioid use in heart failure (HF) management is controversial, and
whether rapid symptomatic relief outweighs the risks of opioid use in HF remains unknown. This …

[PDF][PDF] Antiviral treatment in COVID-19 outpatients: a systematic review of randomized controlled trials

DS Budi, P Oktavian, TP Asmarawati, P Lestari… - Acta Med …, 2022 - researchgate.net
Background: Most COVID-19 patients have mild or moderate illnesses that can progress to
severe illness, leading to hospitalization and/or mortality. The use of antivirals to prevent the …

The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trials

IA Wafa, NR Pratama, DS Budi, H Sutanto, AN Rosyid… - medRxiv, 2021 - medrxiv.org
Objectives The use of monoclonal antibody for COVID-19 showed conflicting results in prior
studies and its efficacy remains unclear. We aimed to comprehensively determine the …

[PDF][PDF] SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies

JC Sutadji, DAP Musalim, DS Budi, J Susanto… - Journal of Pharmacy & …, 2024 - jppres.com
Context: Diabetic nephropathy is the leading cause of end-stage renal disease and also
death in the world. Administration of Szeto-Schiller-31 (SS-31) as a potential therapeutic …